Clinical Trial Update: Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating different doses of neostigmine to reverse moderate neuromuscular blockade in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade Complications in Pediatric Patients

Drugs mentioned

• Neostigmine (neostigmine)

Snippet

Sponsor: Pontificia Universidade Catolica de Sao Paulo | Conditions: Neuromuscular Blockade, Neuromuscular Block, Residual | Phase 4 | Status: UNKNOWN